Measurabl, ESG data management platform for commercial real estate, $93M Series D with Energy Impact Partners, Sway Ventures
Kate Therapeutics, develops adeno-associated virus (AAV)-based gene therapies to treat genetically defined muscle and heart diseases, $51M Series A with Versant Ventures, Westlake Village BioPartners
Debut, unconventional innovation company that integrates breakthrough biotechnology and brand creation, $34M Series B with Business Opportunities for L'Oréal Development
Mosaic.tech, finance platform that provides predictive reporting capabilities to assist with financial strategy and planning, $26M Series C with OMERS Ventures
Modulo Bio, develop drugs that enhance neuroimmune system to treat neurological conditions, $8M Series A with Hawktail Management, Bioverge
Visgenx, develops therapeutics to protect against the loss of sight from retinal disorders, $2.8M
Influence Studios, provides a photo and video rental studio that features 12 sets styled for clients' production needs, $325K Seed